\
&
Contact us
\
&
Contact us
Published on | 2 months ago
Programmes Security Digital, Industry & Space CybersecurityThe NIS Cooperation Group has launched a survey to collect feedback aimed at guiding the future steps towards implementing quantum-safe cryptography in Europe. This initiative follows the release of the "Coordinated Implementation Roadmap for the Transition to Post-Quantum Cryptography (PQC)". Quantum computing poses significant challenges to data security, and the European Commission aims to collaborate with stakeholders to address these challenges.
The public consultation aims to gather input from providers of critical infrastructures, industry stakeholders, and academia. Participants are encouraged to review the existing roadmap and submit concrete proposals, especially those addressing specific sector challenges. Suggestions may include mentioning open-source tools that can assist in this transition.
Feedback will be accepted until 29 September 2025 (18:00 CEST). Contributions will be reviewed and promising proposals may be invited to provide further details and input for the updated roadmap.
For more information and the link to the survey, please visit the dedidated website.
Background:
The Network and Information Systems Cooperation Group (NIS Cooperation Group) was established by the NIS Directive to ensure cooperation and information exchange among Member States, the European Commission and the EU Agency for cybersecurity (ENISA). Among the key outputs of the NIS Cooperation Group, there are non-binding guidelines to the EU Members States to allow effective and coherent implementation of the NIS Directive across the EU and to address wider cybersecurity policy issues.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Digital Europe AI Continent Advanced Digital Skills Deployment: Best use of technologies
The European Commission has recently published the first amendment to the Digital Europe Main Work Programme 2025-2027, taking into account the most recent political priorities of the Commission. Among the main changes, the programme will now contribute to the landmark AI Gigafactories initiative, set to accelerate the development of cutting... read more
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
